Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile

被引：6
|
作者：
Crawford, ED [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80010 USA
来源：
BJU INTERNATIONAL | 2005年 / 95卷
关键词：
LUTS; BPH; alpha(1)-adrenoceptor antagonists; 5 alpha-reductase inhibitors; efficacy; tolerability; disease progression;
D O I：
10.1111/j.1464-410X.2005.05484.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [21] Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management
    Barkin, Jack
    CANADIAN JOURNAL OF UROLOGY, 2011, 18 : 14 - 19
  • [22] Reasons for Prescription Change of α1-Blockers in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
    Kim, Tae Nam
    Nam, Jong Kil
    Lee, Ki Soo
    Kim, Tae Hyo
    Park, Sung Woo
    Shin, Dong Gil
    Park, Hyun Jun
    Lee, Wan
    Lee, Zeong Zoo
    Chung, Moon Kee
    UROLOGY, 2014, 84 (02) : 427 - 432
  • [23] Assessment of Patient-Reported Outcome of Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and Treated With Tamsulosin HCl in Korea
    Chang, Hyuk Soo
    Park, Choal Hee
    Kim, Dae Kyung
    Park, Jong Kwan
    Hong, Sung Joon
    Chung, Byung Ha
    Lee, Jeong Gu
    Kim, Choung-Soo
    Lee, Kyu-Sung
    Kim, Joon Chul
    UROLOGY, 2010, 75 (05) : 1156 - 1161
  • [24] Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction
    Calogero, Aldo E.
    Burgio, Giovanni
    Condorelli, Rosita A.
    Cannarella, Rossella
    La Vignera, Sandro
    AGING MALE, 2018, 21 (04): : 272 - 280
  • [25] Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
    Pattanaik, Smita
    Mavuduru, Ravimohan S.
    Panda, Arabind
    Mathew, Joseph L.
    Agarwal, Mayank M.
    Hwang, Eu Chang
    Lyon, Jenifer A.
    Singh, Shrawan K.
    Mandal, Arup K.
    BJU INTERNATIONAL, 2019, 124 (01) : 27 - 34
  • [26] Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia
    Gallegos, Patrick J.
    Frazee, Lawrence A.
    PHARMACOTHERAPY, 2008, 28 (03): : 356 - 365
  • [27] Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries
    Fourcade, Richard-Olivier
    Theret, Nathalie
    Taieb, Charles
    BJU INTERNATIONAL, 2008, 101 (09) : 1111 - 1118
  • [28] Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia
    Djavan, Bob
    Handl, Markus Johannes
    Dianat, Saeid
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (15) : 2535 - 2547
  • [29] Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
    Chapple, Christopher
    CURRENT OPINION IN UROLOGY, 2010, 20 (01) : 43 - 48
  • [30] Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
    Zhu, Ling-ling
    Feng, Zhi-jun
    Zhou, Quan
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 621 - 622
12345